Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 3
1982 17
1983 32
1984 34
1985 48
1986 50
1987 34
1988 37
1989 41
1990 30
1991 42
1992 37
1993 35
1994 31
1995 30
1996 30
1997 35
1998 39
1999 41
2000 31
2001 42
2002 42
2003 32
2004 52
2005 49
2006 42
2007 55
2008 50
2009 50
2010 53
2011 48
2012 59
2013 58
2014 60
2015 77
2016 63
2017 72
2018 67
2019 74
2020 69
2021 65
2022 99
2023 105
2024 94
2025 87

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,079 results

Results by year

Filters applied: . Clear all
Page 1
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome.
Huang Z, Brodeur KE, Chen L, Du Y, Wobma H, Hsu EE, Liu M, Chang JC, Chang MH, Chou J, Day-Lewis M, Dedeoglu F, Halyabar O, Lederer JA, Li T, Lo MS, Lu M, Meidan E, Newburger JW, Randolph AG, Son MB, Sundel RP, Taylor ML, Wu H, Zhou Q, Canna SW, Wei K, Henderson LA, Nigrovic PA, Lee PY. Huang Z, et al. J Clin Invest. 2023 Nov 15;133(22):e165616. doi: 10.1172/JCI165616. J Clin Invest. 2023. PMID: 37751296 Free PMC article.
The type I interferonopathies: 10 years on.
Crow YJ, Stetson DB. Crow YJ, et al. Nat Rev Immunol. 2022 Aug;22(8):471-483. doi: 10.1038/s41577-021-00633-9. Epub 2021 Oct 20. Nat Rev Immunol. 2022. PMID: 34671122 Free PMC article. Review.
Type I Interferonopathies: A Clinical Review.
Wang CS. Wang CS. Rheum Dis Clin North Am. 2023 Nov;49(4):741-756. doi: 10.1016/j.rdc.2023.06.002. Epub 2023 Jul 19. Rheum Dis Clin North Am. 2023. PMID: 37821193 Review.
Assessment of type I interferon signatures in undifferentiated inflammatory diseases: A Japanese multicenter experience.
Miyamoto T, Honda Y, Izawa K, Kanazawa N, Kadowaki S, Ohnishi H, Fujimoto M, Kambe N, Kase N, Shiba T, Nakagishi Y, Akizuki S, Murakami K, Bamba M, Nishida Y, Inui A, Fujisawa T, Nishida D, Iwata N, Otsubo Y, Ishimori S, Nishikori M, Tanizawa K, Nakamura T, Ueda T, Ohwada Y, Tsuyusaki Y, Shimizu M, Ebato T, Iwao K, Kubo A, Kawai T, Matsubayashi T, Miyazaki T, Kanayama T, Nishitani-Isa M, Nihira H, Abe J, Tanaka T, Hiejima E, Okada S, Ohara O, Saito MK, Takita J, Nishikomori R, Yasumi T. Miyamoto T, et al. Front Immunol. 2022 Sep 23;13:905960. doi: 10.3389/fimmu.2022.905960. eCollection 2022. Front Immunol. 2022. PMID: 36211342 Free PMC article.
2,079 results